Computational Tool Development for Integrative Systems Biology Data Analysis Summary of Projects Awarded in 2020 Under Funding Opportunity Announcement DE-FOA-0002217
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
The 'Omics Revolution: How an Obsession with Compiling Lists Is
The ‘omics revolution: how an obsession with compiling lists is threatening the ancient art of experimental design. Claudio D Stern Department of Cell & Developmental Biology, University College London, Gower Street, London WC1E 6BT, UK. [email protected] The last quarter of a century ushered in a transformation in Biology following the huge successes in sequencing entire genomes of organisms (including humans) with increasing precision and speed and rapidly decreasing cost: genomics. Later other “omics” approaches followed: proteomics, metabolomics, epigenomics, and many more. Huge quantities of data were generated and new computational methods to find hidden correlations emerged. Almost imperceptibly, however, it seems that this has led to a crisis in our ability to design elegant experiments to establish causality. Imagine an extra-terrestrial excursion to planet Earth to discover about life on this planet. A spaceship with alien scientists lands in a park with many statues on display, representing important people from British history. The aliens unload their sophisticated analytical equipment and start to investigate. The first one uses a mass spectrometer – s/he approaches each statue and analyse it: one statue contains 5% copper, 10% iron, 17% aluminium, 63% lead. Another statue seems to consist mainly of carbon and a little water. A third object is made of granite. And so on. Another scientist follows: their analysis with a powerful super-resolution electron microscope reveals different sets of atomic structures. A third scientist uses a balance and lists the mass of each statue. A fourth measures the dimensions – some statues are very small, others quite large, and they have different overall shapes: some are tall, some are rather rounded. -
From Proteomics to Systems Biology Outline and Learning Objectives
From Proteomics to Systems Biology Outline and learning objectives “Omics” science provides global analysis tools to study entire systems • How to obtain omics - data • What can we learn? Limitations? • Integration of omics - data • In-class practice: Omics-data visualization Integration of “omics”- information Omics - data provide systems-level information Omics - data provide systems-level information Whole-genome sequencing Microarrays 2D-electrophoresis, mass spectrometry Joyce & Palsson, 2006 Joyce & Palsson, 2006 Transcriptomics (indirectly) tells about Proteomics aims to detect and quantify RNA-transcript abundances a system’s entire protein content ! primary genomic readout Strengths: - very good genome-wide coverage - variety of commercial products Drawback: No protein-level info!! -> RNA degradation Strengths: -> Post-translational modifications -> info about post-translational modifications => validation by e.g. RT-PCR -> high throughput possible due to increasing quality and cycle speed of mass spec instrumentation Limitations: - coverage dependent on sample, preparation & separation method - bias towards most highly abundant proteins Omics - data provide systems-level information Metabolomics and Lipidomics Detector Metabolites GC-MS extracted NMR from cell lysate Glycan arrays, Lipids Glyco-gene chips, mass spec / NMR of carbohydrates ESI-MS/MS Joyce & Palsson, 2006 Metabolomics and Lipidomics Metabolomics and Lipidomics Metabolomics: Metabolomics: Large-scale measurement of cellular metabolites Large-scale measurement of -
Impacts of Genomics and Other 'Omics' for the Crop, Forestry, Livestock
Impacts of genomics and other ‘omics’ for the crop, forestry, livestock, fishery and agro-industry sectors in developing countries 1. Introduction Advances in genomics, the study of all the genetic material (i.e. the genome) of an organism, have been remarkable in recent years. Publication of the first draft of the human genome in 2001 was a milestone, quickly followed by that of the first crop (rice) in 2002 and the first farm animal (chicken) in 2004. Huge technological advancements have meant that sequencing has become dramatically quicker and cheaper over time, so the genomes of many of the important crops, livestock, forest trees, aquatic animals and agricultural pests are now already sequenced or soon will be. The FAO Biotechnology Forum (http://www.fao.org/biotech/biotech-forum/) is hosting this e-mail conference to look at the impacts that genomics, and the other related 'omics', have had so far on food and agriculture in developing countries as well as their potential impacts in the near future. Before looking at genomics in more detail, a quick overview of some basic genetic concepts can be provided [for more technical details, see FAO (2011a) or the FAO biotechnology glossary (FAO, 2001)]. All living things are made up of cells that contain genetic material called DNA, a molecule made up of a long chain of nitrogen-containing bases (of four kinds: A, C, G and T). DNA is organized as a double helix, where two DNA chains are held together through bonding of the bases, where A bonds with T and C bonds with G. -
2011 Annual Report of the Georgia Research Alliance Not Every Day Brings a Major Win, but in 2011, Many Did
2011 AnnuAl report of the GeorGiA reseArch AlliAnce not every day brings a major win, but in 2011, many did. An advance in science, a venture investment, the growth of a company – these kinds of developments, all connected in some way to the catalytic efforts of the Georgia research Alliance, signaled that Georgia’s technology-rich economy is alive and growing. And that’s good news. In GRA, Georgia has a game Beginning in July, GRA partnered These and other 2011 events Competition among states for plan for building the science- with the Georgia Department and activities represent a economic development and job and technology-driven of Economic Development to foundation for future creation is as intense as ever. economy of tomorrow. And determine how the state’s seven advances, investments and Every advantage matters. GRA in 2011, that game plan was Centers of Innovation, which economic growth. As such, bolsters Georgia’s competitive strengthened when newly help grow strategic industries, they are a reminder that it advantage by expanding elected Governor Nathan Deal can maximize their potential. pays to make every day count. university R&D capacity and moved to align more closely And the Georgia Cancer adding the fuel needed to several of Georgia’s greatest Coalition, the state’s signature launch new enterprises. assets for creating, expanding initiative for cancer research and attracting companies and care, was moved under the that foster high-wage jobs. GRA umbrella. the events of 2011 | JAnuArY – feBruArY Jan 1 Expert in autism named GRA Eminent Scholar Jan 11 Collaboration aims to develop new treatment for ovarian cancer Georgia Tech researchers have Meg Buscema proposed a filtration system that could potentially remove Billy Howard Jan 4 free-floating cancer cells that cause secondary tumors. -
New Technologies and Their Impact on 'Omics' Research
Available online at www.sciencedirect.com New technologies and their impact on ‘omics’ research Editorial overview Matthew Bogyo and Pauline M Rudd Current Opinion in Chemical Biology 2013, 17:1–3 For a complete overview see the Issue 1367-5931/$ – see front matter, Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.cbpa.2013.01.005 Matthew Bogyo The use of the suffix ‘ome’ is defined in the Oxford English dictionary as ‘being used in cellular and molecular biology to form nouns with the sense Department of Pathology, Stanford University ‘‘all constituents considered collectively’’’. Interestingly, the use of the School of Medicine, Stanford, CA, USA e-mail: [email protected] ‘ome’ suffix in biology dates back to the early 1900s when it was first used to describe a ‘biome’ and genome (although originally in German as genom). Matthew Bogyo received his BSc degree in Over the past few decades, the use of the omics suffix has rapidly increased, Chemistry from Bates College in 1993 and a due in a large part, to the rapid growth in technologies that allow global PhD in Biochemistry from the Massachusetts analysis of samples on a systems level. The familiarity of the ‘omics’ term Institute of Technology in 1997. He became a also was rapidly advanced by the completion of the human genome in the Faculty Fellow at the University of California, early 2000s. Since that time, we have seen the term ‘omics’ move beyond use San Francisco in 1998. In 2001, he moved to for genomics and proteomics and gain acceptance for a diverse array of Celera Genomics to head the Department of Chemical Proteomics until 2003 when he systems biology applications. -
For Ligand- Binding Site Prediction and Functional Annotation
A threading-based method (FINDSITE) for ligand- binding site prediction and functional annotation Michal Brylinski and Jeffrey Skolnick* Center for the Study of Systems Biology, School of Biology, Georgia Institute of Technology, 250 14th Street NW, Atlanta, GA 30318 Edited by Harold A. Scheraga, Cornell University, Ithaca, NY, and approved November 19, 2007 (received for review August 15, 2007) The detection of ligand-binding sites is often the starting point for Connolly surface (21) and then reranks the identified pockets by protein function identification and drug discovery. Because of the degree of conservation of identified surface residues. inaccuracies in predicted protein structures, extant binding pocket- A systematic analysis of known protein structures grouped detection methods are limited to experimentally solved structures. according to SCOP (22) reveals a general tendency of certain Here, FINDSITE, a method for ligand-binding site prediction and protein folds to bind substrates at a similar location, suggesting functional annotation based on binding-site similarity across that analogous or very distantly homologous proteins can have groups of weakly homologous template structures identified from common binding sites (11). If so, it should be possible to develop threading, is described. For crystal structures, considering a cutoff an approach for ligand-binding site identification that is less distance of4Åasthehitcriterion, the success rate is 70.9% for sensitive than pocket-detection methods to distortions in the identifying -
Daisuke Kihara, Ph.D. Professor of Biological Sciences and Computer Science Purdue University
Updated on June 21, 2020 Daisuke Kihara, Ph.D. Professor of Biological Sciences and Computer Science Purdue University Contact Information Purdue University Department of Biological Sciences and Computer Science West Lafayette, IN, 47907 Office: Hockmyer 229 Tel: (765) 496-2284 E-mail: [email protected] https://www.bio.purdue.edu/People/faculty_dm/directory.php?refID=166 https://www.cs.purdue.edu/people/faculty/dkihara/ http://kiharalab.org (Lab) Education 1999 Ph.D. (Science) in Bioinformatics Kyoto University, Faculty of Science, Japan, Advisor: Minoru Kanehisa 1996 M.S. in Bioinformatics Kyoto University, Faculty of Science, Japan 1994 B.S. in Interdisciplinary Science The University of Tokyo, College of Arts and Sciences, Japan Positions held 2019.3-present Full member, Purdue University Center for Cancer Research 2014.8-present Full Professor 2018.3-present Adjunct Professor, University of Cincinnati, Department of Pediatrics 2015.1-2015.8 Visiting Scientist, Eli Lilly, Indianapolis 2009.8-2014.8 Associate professor 2003.8-2009.8 tenure-track Assistant professor Purdue University, West Lafayette, Indiana Department of Biological Sciences/Computer Sciences (joint appointment) 2002.9-2003.7 Senior Postdoctoral Research Associate Advisor: Jeffrey Skolnick Buffalo Center of Excellence in Bioinformatics, Buffalo, NY, USA 1999-2002.9 Postdoctoral Research Associate Advisor: Jeffrey Skolnick Donald Danforth Plant Science Center, St. Louis, MO, USA 1998-1999 Research Assistant Advisor: Minoru Kanehisa Bioinformatics Center, Institute for -
Jacquelyn S. Fetrow
Jacquelyn S. Fetrow President and Professor of Chemistry Albright College Curriculum Vitae Office of the President Work Email: [email protected] Library and Administration Building Office Phone: 610-921-7600 N. 13th and Bern Streets, P.O. Box 15234 Reading, PA 19612 Education Ph.D. Biological Chemistry, December, 1986 B.S. Biochemistry, May, 1982 Department of Biological Chemistry Albright College, Reading, PA The Pennsylvania State University College of Medicine, Hershey, PA Graduated summa cum laude Loops: A Novel Class of Protein Secondary Structure Thesis Advisor: George D. Rose Professional Experience Albright College, Reading PA President and Professor of Chemistry June 2017-present University of Richmond, Richmond, VA Provost and Vice President of Academic Affairs July 2014-December 2016 Professor of Chemistry July 2014-May 2017 Responsibilities as Provost: Chief academic administrator for all academic matters for the University of Richmond, a university with five schools (Arts and Sciences, Business, Law, Leadership, and Professional and Continuing Studies), ~400 faculty and ~3300 full-time undergraduate and graduate students; manage the ~$91.8M annual operating budget of the Academic Affairs Division, as well as endowment and gift accounts; oversee Richmond’s Bonner Center of Civic Engagement (engage.richmond.edu), Center for International Education (international.richmond.edu), Registrar (registrar.richmond.edu), Office of Institutional Effectiveness (ifx.richmond.edu), as well as other programs and staff; partner with VP -
S41598-018-25035-1.Pdf
www.nature.com/scientificreports OPEN An Innovative Approach for The Integration of Proteomics and Metabolomics Data In Severe Received: 23 October 2017 Accepted: 9 April 2018 Septic Shock Patients Stratifed for Published: xx xx xxxx Mortality Alice Cambiaghi1, Ramón Díaz2, Julia Bauzá Martinez2, Antonia Odena2, Laura Brunelli3, Pietro Caironi4,5, Serge Masson3, Giuseppe Baselli1, Giuseppe Ristagno 3, Luciano Gattinoni6, Eliandre de Oliveira2, Roberta Pastorelli3 & Manuela Ferrario 1 In this work, we examined plasma metabolome, proteome and clinical features in patients with severe septic shock enrolled in the multicenter ALBIOS study. The objective was to identify changes in the levels of metabolites involved in septic shock progression and to integrate this information with the variation occurring in proteins and clinical data. Mass spectrometry-based targeted metabolomics and untargeted proteomics allowed us to quantify absolute metabolites concentration and relative proteins abundance. We computed the ratio D7/D1 to take into account their variation from day 1 (D1) to day 7 (D7) after shock diagnosis. Patients were divided into two groups according to 28-day mortality. Three diferent elastic net logistic regression models were built: one on metabolites only, one on metabolites and proteins and one to integrate metabolomics and proteomics data with clinical parameters. Linear discriminant analysis and Partial least squares Discriminant Analysis were also implemented. All the obtained models correctly classifed the observations in the testing set. By looking at the variable importance (VIP) and the selected features, the integration of metabolomics with proteomics data showed the importance of circulating lipids and coagulation cascade in septic shock progression, thus capturing a further layer of biological information complementary to metabolomics information. -
A Metabolomics Approach to Pharmacotherapy Personalization
Journal of Personalized Medicine Review A Metabolomics Approach to Pharmacotherapy Personalization Elena E. Balashova *, Dmitry L. Maslov and Petr G. Lokhov Institute of Biomedical Chemistry, Pogodinskaya St. 10, Moscow 119121, Russia; [email protected] (D.L.M.); [email protected] (P.G.L.) * Correspondence: [email protected] Received: 29 June 2018; Accepted: 3 September 2018; Published: 5 September 2018 Abstract: The optimization of drug therapy according to the personal characteristics of patients is a perspective direction in modern medicine. One of the possible ways to achieve such personalization is through the application of “omics” technologies, including current, promising metabolomics methods. This review demonstrates that the analysis of pre-dose metabolite biofluid profiles allows clinicians to predict the effectiveness of a selected drug treatment for a given individual. In the review, it is also shown that the monitoring of post-dose metabolite profiles could allow clinicians to evaluate drug efficiency, the reaction of the host to the treatment, and the outcome of the therapy. A comparative description of pharmacotherapy personalization (pharmacogenomics, pharmacoproteomics, and therapeutic drug monitoring) and personalization based on the analysis of metabolite profiles for biofluids (pharmacometabolomics) is also provided. Keywords: pharmacometabolomics; metabolomics; pharmacogenomics; therapeutic drug monitoring; personalized medicine; mass spectrometry 1. Introduction The uniformity of the drug response or low inter-individual differences in drug response are commonly accepted tenets in the field of medicine. Almost all drugs are prescribed on the basis of this statement. This approach can be described as treatment of the “average patient” by “the average pill” or “one size fits all”. However, clinicians have long observed that the actual effectiveness of the pharmacotherapy may be variable. -
Tertiary Structure Predictions on a Comprehensive Benchmark of Medium to Large Size Proteins
Biophysical Journal Volume 87 October 2004 2647–2655 2647 Tertiary Structure Predictions on a Comprehensive Benchmark of Medium to Large Size Proteins Yang Zhang and Jeffrey Skolnick Center of Excellence in Bioinformatics, University at Buffalo, Buffalo, New York 14203 ABSTRACT We evaluate tertiary structure predictions on medium to large size proteins by TASSER, a new algorithm that assembles protein structures through rearranging the rigid fragments from threading templates guided by a reduced Ca and side-chain based potential consistent with threading based tertiary restraints. Predictions were generated for 745 proteins 201– 300 residues in length that cover the Protein Data Bank (PDB) at the level of 35% sequence identity. With homologous proteins excluded, in 365 cases, the templates identified by our threading program, PROSPECTOR_3, have a root-mean-square deviation (RMSD) to native , 6.5 A˚ , with .70% alignment coverage. After TASSER assembly, in 408 cases the best of the top five full-length models has a RMSD , 6.5 A˚ . Among the 745 targets are 18 membrane proteins, with one-third having a predicted RMSD , 5.5 A˚ . For all representative proteins less than or equal to 300 residues that have corresponding multiple NMR structures in the Protein Data Bank, 20% of the models generated by TASSER are closer to the NMR structure centroid than the farthest individual NMR model. These results suggest that reasonable structure predictions for nonhomologous large size proteins can be automatically generated on a proteomic scale, and the application of this approach to structural as well as functional genomics represent promising applications of TASSER. INTRODUCTION The protein structure prediction problem, that is, deducing a RMSD , 7A˚ in the top five models (Simons et al., 2001). -
Multi-Omics: an Opportunity to Dive Into Systems Biology
Brazilian Journal of Analytical Chemistry 2020, Volume 7, Issue 29, pp 18-44 doi: 10.30744/brjac.2179-3425.RV-03-2020 REVIEW Multi-omics: An Opportunity to Dive into Systems Biology Emerson Andrade Ferreira dos Santos1 Elisa Castañeda Santa Cruz1 Henrique Caracho Ribeiro1 Luidy Darllan Barbosa1 Flávia da Silva Zandonadi1 Alessandra Sussulini1,2,* 1Laboratory of Bioanalytics and Integrated Omics (LaBIOmics), Department of Analytical Chemistry, Institute of Chemistry, University of Campinas (UNICAMP), P.O. Box 6154, 13083-970, Campinas, SP, Brazil 2National Institute of Science and Technology for Bioanalytics – INCTBio, Institute of Chemistry, University of Campinas (UNICAMP), P.O. Box 6154, 13083-970, Campinas, SP, Brazil Omics data integration employing multi-omics approach is an outstanding opportunity to design a reliable picture of the biochemistry and dynamics of biological systems, as well as prioritize strategies for biomarker discovery. Biological functions are characterized by complex interaction networks, in which the dynamics of biomolecules manages physical and biochemical processes. However, since the emergence of omic sciences, researchers are still looking for the most accurate method to classify and determine the identity and function of biomarkers that describe a system and the ongoing biological processes. Thus, according to the strategies unveiled in the multi-omics literature, this is considered a challenging science field. Therefore, this review describes a workflow example regarding multi-omics data integration, indicating mathematical and computational tools in analysis pipelines that use various methods to perform a sequence of tasks, which would be able to describe biological processes within the systems biology context. Keywords: multi-omics, data integration tools, omics INTRODUCTION The application of computational and mathematical modeling towards a deeper and broader understanding of biological systems is called systems biology.